Double-Digit Growth Forecast for China’s Stent Retriever Market

Stroke, considered a prominent non-communicable disease, has a significant impact on mortality and disability rates in China. With the country’s increasing population and prevalence of risk factors for ischemic stroke (diabetes, hypertension, and hyperlipidemia, among others), China’s stent retriever market is set to expand 10% annually through 2033, forecasts GlobalData.
 
The company’s report, “Neurovascular Thrombectomy Devices Market Size By Segments, Share, Regulatory And Reimbursement, Procedures And Forecast To 2033,” reveals that China’s stent retriever sector accounts for about 40% of Asia-Pacific’s (APAC) current market, thanks primarily due to the country’s steadily rising ischemic incident cases, which are anticipated to reach 2 million by 2033.
 
The increasing incidence of ischemic stroke cases has led to an increased need for more sophisticated stent retrievers. Consequently, the National Medical Products Administration (NMPA) in China earlier this year approved the Tigertriever revascularization device to treat ischemic stroke. Rapid Medical claims the Tigertriever revascularization device is pioneering patient-specific solutions for removing brain blood clots and thereby is advancing ischemic stroke treatment.
 
“In the past few years, there has been an increase in the use of stent retrievers to treat ischemic strokes. However, most of the conventional stent retrievers have limitations such as difficulty navigating wire in delicate intracranial vessels, limited stretchability, and force per unit length, which remains a critical issue,” GlobalData Medical Devices Analyst Shraddha Sapkal said. 
 
The Tigertriever revascularization device addresses the limitations of most conventional stents, offering doctors the capability to enhance their precision and control while performing procedures and managing unexpected challenges. This approach shifts these procedures from passive to active, streamlining clot capture and potentially reducing the risk of blood vessel injury during clot removal, resulting in higher revascularization rates.
 
“To sum it up, as stroke evolves as a serious medical concern, there is a pressing need for devices that offer good control, high safety, and efficacy,” Sapkal stated. “The evolution of devices such as Tigertriever brings forth a promising future for managing ischemic stroke in China.”